Product Information
REBIF REBIDOSE 44 MCG/0.5 ML is a brand product labeled by EMD Serono, Inc., priced at $1848.6728 per ML under NDC 44087334401. Its NADAC has been published 111 times since Aug 21, 2024.
Strength
44 ug/.5mL
Manufacturer
EMD Serono, Inc.NDC
44087334401
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
1/3/2026
Active Ingredients
INTERFERON BETA-1AApproval Type
Biologic (BLA)
FDA Application
BLA103780On Market Since
12/21/2012
Pharmacological Classes
Price Statistics
The NADAC for REBIF REBIDOSE 44 MCG/0.5 ML has been published 111 times since Aug 21, 2024, and over the history we have for it it has risen 8.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1848.6728 per ML |
|---|---|
| All-time high | $1848.6728 (Sep 30, 2026) |
| All-time low | $1700.1957 (Aug 21, 2024) |
| 52-week high | $1848.6728 |
| 52-week low | $1777.5700 |
| Median price | $1777.5700 |
| Average price | $1787.0439 |
| Largest weekly change | +4.0% (Feb 5, 2025) |
| Weeks tracked | 111 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the INTERFERON BETA-1A market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
EMD Serono, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
INTERFERON BETA-1A market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of REBIF REBIDOSE 44 MCG/0.5 ML?
The current National Average Drug Acquisition Cost (NADAC) for REBIF REBIDOSE 44 MCG/0.5 ML, manufactured by EMD Serono, Inc., is $1848.6728 per ML (NDC 44087334401), effective Sep 30, 2026.
How has the price of REBIF REBIDOSE 44 MCG/0.5 ML changed over time?
Over the history we have for it, the NADAC for REBIF REBIDOSE 44 MCG/0.5 ML has risen 8.7%. It has been tracked across 111 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for REBIF REBIDOSE 44 MCG/0.5 ML?
Since Aug 21, 2024, the NADAC for REBIF REBIDOSE 44 MCG/0.5 ML has ranged from a low of $1700.1957 (Aug 21, 2024) to a high of $1848.6728 (Sep 30, 2026), with a median of $1777.5700 per ML.
Are there cheaper alternatives to REBIF REBIDOSE 44 MCG/0.5 ML?
No other NADAC-published product currently shares the active ingredient and strength of REBIF REBIDOSE 44 MCG/0.5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures REBIF REBIDOSE 44 MCG/0.5 ML?
REBIF REBIDOSE 44 MCG/0.5 ML (NDC 44087334401) is labeled by EMD Serono, Inc., and CMS classifies it as a brand product.